Table 1 Demographic characteristics of patients and normal subjects
From: KIAA1199 as a potential diagnostic biomarker of rheumatoid arthritis related to angiogenesis
| Â | Normal | Inactive rheumatoid arthritis (disease activity score in 28 joints <3.2) | Active rheumatoid arthritis (disease activity score in 28 joints >3.2) | Osteoarthritis | AS |
|---|---|---|---|---|---|
Number | 15 | 19 | 25 | 15 | 15 |
Age, years | 47.2 ± 9.91 | 53.64 ± 6.32 | 57.56 ± 9.75 | 54.65 ± 8.43 | 38.75 ± 9.34 |
Male/female, n | 6/9 | 8/11 | 10/15 | 7/8 | 8/7 |
Serum C-reactive protein, mg/dl | 0.19 ± 0.09 | 0.20 ± 0.07 | 1.37 ± 0.89 | 0.18 ± 0.04 | 0.38 ± 0.17 |
Disease activity in 28 joints, score | 0.94 ± 0.41 | 2.57 ± 1.35 | 5.38 ± 3.93 | NA | NA |
Erythrocyte sedimentation rate, mm/h | 9.83 ± 3.06 | 28.35 ± 13.41 | 47.36 ± 29.41 | 10.57 ± 2.44 | 36.9 ± 13.52 |
Duration of disease, years | NA | 4.1 ± 2.7 | 8.3 ± 4.3 | 6.4 ± 2.9 | 10.6 ± 5.8 |
Bath ankylosing spondylitis disease activity index, score | NA | NA | NA | NA | 7. 85 ± 5.24 |
Non-steroidal anti-inflammatory drug usage, % | NA | 78.3 | 81.3 | NA | 46.6 |
Disease-modifying anti-rheumatic drug usage, % | NA | 63.5 | 65.1 | NA | 38.9 |